BioNTech SE BNTX
NASDAQ BNTX
$87.21 -0.30 (-0.34%)
At close: Nov 10, 2026 · 4:00 PM EST

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2025)

Updated

BioNTech SE's Current Deferred Tax Assets came in at $80.23 million for Q4 2025, compared with -$17.07 million a year earlier.

Analysis

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2025) Analysis & Trends

Going back to Q4 2020, BioNTech SE's Current Deferred Tax Assets data covers 9 quarters.

  • Current Deferred Tax Assets carries a five-year compound annual growth rate of 18.4% (FY2020 to FY2025).
  • Going back by year, Current Deferred Tax Assets was -$17.07 million in FY2024, -$15.83 million in FY2023, $32.62 million in FY2022 (-40.6%) and $54.93 million in FY2021 (+59.5%).
  • The Q4 2025 figure represents the highest quarterly Current Deferred Tax Assets since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 BioNTech SE 21.19 Bn -49.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 80.23 Mn
Dec 31, 2024 -17.07 Mn
Dec 31, 2023 -15.83 Mn
Dec 31, 2022 32.62 Mn
Sep 30, 2022 71.76 Mn
Jun 30, 2022 78.98 Mn
Mar 31, 2022 90.08 Mn
Dec 31, 2021 54.93 Mn
Dec 31, 2020 34.44 Mn
API Access

BioNTech SE Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BNTX&period=max&api_key=YOUR_API_KEY